
|Articles|August 7, 2020
How will COVID-19 impact value-based models?
Author(s)Jessica Barry
COVID-19 has left providers with fewer in-office visits, more telehealth appointments and, for many, reduced revenue.
Advertisement
But even as doctors struggle with the day-to-day challenges of practicing under radically new circumstances, some health care policy makers, academics and payers are asking another question: What do the changes caused by the pandemic mean for accountable care organizations (ACOs) and other value-based care models, under which doctors and practices are rewarded for keeping patients healthy while holding costs down?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
2
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
3
Social Media Mythbusters: The Summer Skin Care "Shutdown"
4
Phase 2 Trial Supports Oral VDPHL01 for Female Pattern Hair Loss
5











